{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:26:50Z","timestamp":1792654010812,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.biomaterials.2013.06.047","type":"journal-article","created":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T07:15:14Z","timestamp":1373786114000},"page":"7733-7743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption"],"prefix":"10.1016","volume":"34","author":[{"given":"Huining","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan E.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.06.047_bib1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","article-title":"Oral insulin - a review of current status","volume":"12","author":"Iyer","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib3","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A\u00a0review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","article-title":"Current challenges in non-invasive insulin delivery systems: a comparative review","volume":"59","author":"Khafagy el","year":"2007","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2009.06.002","article-title":"Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin","volume":"73","author":"Woitiski","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib7","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/j.biomaterials.2010.01.045","article-title":"Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin","volume":"31","author":"Yin","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib8","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib9","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1208\/ps030317","article-title":"Low molecular weight protamine (LMWP) as nontoxic heparin\/low molecular weight heparin antidote (I): preparation and characterization","volume":"3","author":"Chang","year":"2001","journal-title":"AAPS PHARMSCI"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/ps030318","article-title":"Low molecular weight protamine (LMWP) as nontoxic heparin\/low molecular weight heparin antidote (II): in\u00a0vitro evaluation of efficacy and toxicity","volume":"3","author":"Chang","year":"2001","journal-title":"AAPS PHARMSCI"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1208\/ps030319","article-title":"Low molecular weight protamine as nontoxic heparin\/low molecular weight heparin antidote (III): Preliminary in\u00a0vivo evaluation of efficacy and toxicity using a canine model","volume":"3","author":"Chang","year":"2001","journal-title":"AAPS PHARMSCI"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In\u00a0vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-6147(99)01429-7","article-title":"In\u00a0vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA","volume":"21","author":"Schwarze","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib15","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1096\/fj.04-2322fje","article-title":"Nontoxic membrane translocation peptide from protamine, LMWP, for enhanced intracellular protein delivery - in\u00a0vitro and in\u00a0vivo study","volume":"19","author":"Park","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib16","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1023\/A:1022109905487","article-title":"A\u00a0less toxic heparin antagonist- low molecular weight protamine","volume":"68","author":"Liang","year":"2003","journal-title":"Biochemistry-Moscow+"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0049-3848(00)00427-8","article-title":"Reduced reactivity towards anti-protamine antibodies of a LMWP analogue","volume":"101","author":"Tsui","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj1730723","article-title":"Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent","volume":"173","author":"Carlsson","year":"1978","journal-title":"Biochem J"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3565(24)38943-8","article-title":"Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats","volume":"295","author":"Xia","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/bc050344k","article-title":"Synthesis and characterization of insulin-transferrin conjugation","volume":"17","author":"Kavimandan","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A\u00a0novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.biomaterials.2009.11.001","article-title":"The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine","volume":"31","author":"Choi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jgm.402","article-title":"Low molecular weight protamine as an efficient and nontoxic gene carrier: in\u00a0vitro study","volume":"5","author":"Park","year":"2003","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib25","doi-asserted-by":"crossref","first-page":"42625","DOI":"10.1074\/jbc.M301431200","article-title":"Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways","volume":"278","author":"Ignatovich","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib26","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/nar\/gkg385","article-title":"Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells","volume":"31","author":"Simeoni","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib27","doi-asserted-by":"crossref","first-page":"38877","DOI":"10.1074\/jbc.M205395200","article-title":"Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans","volume":"277","author":"Sandgren","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib28","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1074\/jbc.M211891200","article-title":"Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells","volume":"278","author":"Rudolph","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.febslet.2004.04.018","article-title":"Cationic oligopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells","volume":"566","author":"Unnamalai","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.addr.2007.03.004","article-title":"Exogenous siRNA delivery using peptide transduction domains\/cell penetrating peptides","volume":"59","author":"Meade","year":"2007","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.addr.2007.10.004","article-title":"Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides","volume":"60","author":"Meade","year":"2008","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0169-409X(98)00078-7","article-title":"Site-specific insulin conjugates with enhanced stability and extended action profile","volume":"35","author":"Uchio","year":"1999","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","article-title":"Effects of PEG conjugation on insulin properties","volume":"54","author":"Hinds","year":"2002","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj1210737a","article-title":"The acetylation of insulin","volume":"121","author":"Lindsay","year":"1971","journal-title":"Biochem J"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib37","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/elps.200600807","article-title":"Native PAGE eliminates the problem of PEG\u2013SDS interaction in SDS\u2013PAGE and provides an alternative to HPLC in characterization of protein PEGylation","volume":"28","author":"Zheng","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1023\/A:1016045820933","article-title":"In\u00a0vitro permeability through Caco-2 cells is not quantitatively predictive of in\u00a0vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system","volume":"13","author":"Chong","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2009.07.022","article-title":"Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins","volume":"381","author":"Khafagy el","year":"2009","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.chembiol.2004.06.006","article-title":"Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells","volume":"11","author":"Chiu","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.biomaterials.2013.06.047_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2006.10.003","article-title":"RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA","volume":"38","author":"Turner","year":"2007","journal-title":"Blood Cell Mol Dis"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121300762X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121300762X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:51:33Z","timestamp":1758901893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121300762X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":42,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S014296121300762X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.06.047","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}